Acute myocardial infarction

References

• De Wood MA, Spores J. Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980: 303(16): 897–902
   PubMed Web of Science ®Google Scholar
• Reimer KA, Jennings RB. The “wavefront phenomenon” of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979: 40(6): 633–44
   PubMed Web of Science ®Google Scholar
• Standards and guidelines for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiac Care (ECC). JAMA 1986: 255(21): 2905–89 (published erratum appears in JAMA 1986: 256(13): 1727]
   PubMed Web of Science ®Google Scholar
• Thirteenth Bethesda Conference. Emergency cardiac care. Sponsored by the American College of Cardiology September 26 and 27. 1981, Heart House, Bethesda. Maryland. Am J Cardiol 1982: 50(2): 365–420
   Google Scholar
• Wyman MG, Lalka D, Hammersmith L, et al. Multiple bolus technique for lidocaine administration during the first hours of an acute myocardial infarction. Am J Cardiol 1978: 41 (2): 313–7
   PubMed Web of Science ®Google Scholar
• Stargel WW. Shand DG, Routledge PA, et al. Clinical comparison of rapid infusion and multiple injection methods for lidocaine loading. Am Heart J 1981: 102(5): 872–6
   PubMed Web of Science ®Google Scholar
• Lie KI, Wellens HJ. van Capelle FJ, et al. Lidocaine In the prevention of primary ventricular fibrillation: a double-blind, randomized study of 212 consecutive patients. N Engl J Med 1974: 291 (25): 1324–6
   PubMed Web of Science ®Google Scholar
• Klein HO, Jutrin I, Kaplinsky E. Cerebral and cardiac toxicity of a small dose of lignocaine. Br Heart J 1975: 37(7): 775–8
   PubMedGoogle Scholar
• Chatterjee K. Optional regulation of preload and afterload during acute myocardial infarction. In: Califf RM, Wagner GS, eds. Acute coronary care: principles and practice. Boston: Kluwer Academic, 1985: 411–26
   Google Scholar
• Yusuf S. Interventions that potentially limit myocardial infarct size: overview of clinical trials. Am J Cardiol 1987: 60(2): 11–7A
   Google Scholar
• Yusuf S. The use of beta-adrenergic blocking agents, i.v. nitrates and calcium channel blocking agents following acute myocardial infarction. Chest 1988: 93(1 Suppl): 25–8S
   PubMed Web of Science ®Google Scholar
• Yusuf S, Peto R, Lewis J, et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985: 27(5): 335–71
   PubMed Web of Science ®Google Scholar
• First International Study of Infarct Survival (ISIS-1) Collaborative Group. Randomized trial of I.V. atenolol among 16.027 cases of suspected acute myocardial infarction. Lancet 1986: 2(July 12): 57–66
   PubMed Web of Science ®Google Scholar
• Knabb RM, Rosamond TL, Fox KA, et al. Enhancement of salvage of reperfused ischemic myocardium by diltiazem. J Am Coll Cardiol 1986: 8(4): 861–71
   PubMed Web of Science ®Google Scholar
• Roberts R. Recognition, diagnosis, and prognosis of early reinfarction: the role of calcium-channel blockers. Circulation 1987: 75(6 Pt 2): V139–47
   PubMed Web of Science ®Google Scholar
• Gibson RS, Boden WE, Theroux P, et al. Diltiazem and reinfarction in patients with non-Q-wave myocarial infarction: results of a double-blind, randomized, multicenter trial. N Engl J Med 1986: 315(7): 423–9
   PubMed Web of Science ®Google Scholar
• Moss AJ. Secondary prevention with calcium channel-blocking drugs in patients after myocardial infarction: a critical review. Circulation 1987: 75(6 Pt 2): V 148–53
   Web of Science ®Google Scholar
• Gottlieb SO. Effect of nifedipine on clinical course and left ventricular function in low risk acute myocardial infarction: a double-blind randomized trial. (Abstr) Circulation 1984: 70(Suppl II): II–257
   Google Scholar
• The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988: 319(7): 385–92
   PubMed Web of Science ®Google Scholar
• Canner PL. Aspirin in coronary heart disease: comparison of six clinical trials, isr J Med Sci 1983: 19(5): 413–23
   Google Scholar
• Second International Study of Infarct Survival (ISIS-2) Collaborative Group. Randomized trial of I.V. streptokinase, oral aspirin, both or neither among 17.187 cases of suspected acute myocardial infarction J Am Coll Cardiol 1988: 12(6): 3–13A
   Google Scholar
• Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986: 1(8478): 397–402
   PubMed Web of Science ®Google Scholar
• Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet 1987: 2(8564): 871–4
   PubMed Web of Science ®Google Scholar
• AIMS Trial Study Group. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1988: 1 (8585): 545–9
   PubMed Web of Science ®Google Scholar
• O'Rourke M. Limitation of myocardial infarction by early infusion of tissue plasminogen activator. Circulation 1988: 77(6): 1311–5
   PubMed Web of Science ®Google Scholar
• Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987: 76(1): 142–54
   PubMed Web of Science ®Google Scholar
• Anderson JL, Rothbard RL, Hackworthy RA, et al. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase. J Am Coll Cardiol 1988: 11(6): 1153–63
   PubMed Web of Science ®Google Scholar
• Brochier ML, Quilliet L, Kulbertus H, et al. Intravenous anisoylated plasminogen streptokinase activator complex versus intravenous streptokinase in evolving myocardial infarction: preliminary data from a randomised multicentre study. Drugs 1987: 33(Suppl 3): 140–5
   PubMedGoogle Scholar
• Verstraete M, Bernard R, Bory M, et al. Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction: report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator. Lancet 1985: 1(8433): 842–7
   PubMed Web of Science ®Google Scholar
• Badger RS, Brown BG, Kennedy JW, et al. Usefulness of recanalization to luminal diameter of 0.6 millimeter or more with intracoronary streptokinase during acute myocardial infarction in predicting “normal” perfusion status, continued arterial patency and survival at one year. Am J Cardiol 1987: 59(6): 519–22
   PubMed Web of Science ®Google Scholar
• Topol EJ, Califf RM, George BS, et al. A randomized trial: immediate versus delayed elective percutaneous transluminal coronary angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1987: 317(10): 581–8
   PubMed Web of Science ®Google Scholar
• Simoons ML, Arnold AE, Betriu A, et al. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet 1988: 1(8579): 197–203
   PubMed Web of Science ®Google Scholar
• TIMI Study Group. Immediate versus delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction: TIMI II-A results. JAMA 1988: 260(19): 2849–96
   PubMed Web of Science ®Google Scholar
• Guerci AD, Gerstenblith G, Brinker JA, et al. A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty. N Engl J Med 1987: 317(26): 1613–8
   PubMed Web of Science ®Google Scholar
• ACC/AHA Task Force. Guidelines for percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1988: 29(12 Suppl 2): 529–45
   Google Scholar
• Guyton RA, Arcidi JM Jr, Langford DA, et al. Emergency coronary bypass for cardiogenic shock. Circulation 1987: 76(Suppl V): V22–27
   PubMedGoogle Scholar
• DeWood MA, Heit J, Spores J, et al. Anterior transmural myocardial infarction: effects of surgical coronary reperfusion on global and regional left ventricular function. J Am Coll Cardiol 1983: 1 (5): 1223–34
   PubMed Web of Science ®Google Scholar
• Flameng W, Sergeant P, Vanhaecke J, et al. Emergency coronary bypass grafting for evolving myocardial infarction: effects on infarct size and left ventricular function. J Thorac Cardiovasc Surg 1987: 94(1): 124–31
   PubMed Web of Science ®Google Scholar
• Rogers WJ, Smith LR, Oberman A, et al. Surgical vs nonsurgical management of patients after myocardial infarction. Circulation 1980: 62(2 Pt 2): 167–74
   PubMedGoogle Scholar
• O'Rourke RA. Clinical decisions for post myocardial infarction patients. Mod Concepts Cardiovasc Dis 1986: 55(11): 55–60
   Google Scholar
• Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985: 72(6 Pt 2): V123–35
   PubMed Web of Science ®Google Scholar
• Risk stratification and survival after myocardial infarction. N Engl J Med 1983: 309(6): 331–6
   PubMed Web of Science ®Google Scholar
• Moss AJ, DeCamilla JJ, Davis HP, et al. Clinical significance of ventricular ectopic beats in the early posthospital phase of myocardial infarction. Am J Cardiol 1977: 39(5): 635–40
   PubMed Web of Science ®Google Scholar
• Skinner JR, Phillips SJ, Zeff RH, et al. Immediate coronary bypass following failed streptokinase infusion in evolving myocardial infarction. J Thorac Cardiovasc Surg 1984: 87(4): 567–70
   PubMed Web of Science ®Google Scholar
• Montoya A, McKeever L, Scanlon P, et al. Early repair of ventricular septal rupture after infarction. Am J Cardiol 1980: 45(2): 345–8
   PubMed Web of Science ®Google Scholar
• Myers WO, Davis K, Foster ED, et al. Surgical survival in the Coronary Artery Surgery Study (CASS) registry. Ann Thorac Surg 1985: 40(3): 245–60
   PubMed Web of Science ®Google Scholar